{"name":"Bio Genuine (Shanghai) Biotech Co., Ltd.","slug":"bio-genuine-shanghai-biotech-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Add-back therapy","genericName":"Add-back therapy","slug":"add-back-therapy","indication":"Endometriosis (as add-back to GnRH agonist therapy)","status":"phase_3"},{"name":"Placebo for BG2109","genericName":"Placebo for BG2109","slug":"placebo-for-bg2109","indication":"Other","status":"phase_3"},{"name":"Placebo for add-back therapy","genericName":"Placebo for add-back therapy","slug":"placebo-for-add-back-therapy","indication":"Add-back therapy in patients undergoing hormone suppression treatment","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"BG2109","genericName":"BG2109","slug":"bg2109","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"Add-back therapy","genericName":"Add-back therapy","slug":"add-back-therapy","phase":"phase_3","mechanism":"Add-back therapy restores hormonal levels that were suppressed by prior treatment, typically used to mitigate side effects of GnRH agonists in endometriosis or uterine fibroids.","indications":["Endometriosis (as add-back to GnRH agonist therapy)","Uterine fibroids (as add-back to GnRH agonist therapy)"],"catalyst":""},{"name":"BG2109","genericName":"BG2109","slug":"bg2109","phase":"phase_3","mechanism":"BG2109 is a small molecule drug that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"Placebo for BG2109","genericName":"Placebo for BG2109","slug":"placebo-for-bg2109","phase":"phase_3","mechanism":"A placebo control has no active pharmacological mechanism.","indications":[],"catalyst":""},{"name":"Placebo for add-back therapy","genericName":"Placebo for add-back therapy","slug":"placebo-for-add-back-therapy","phase":"phase_3","mechanism":"This drug serves as a placebo for add-back therapy.","indications":["Add-back therapy in patients undergoing hormone suppression treatment"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFB1N2d4NnYwN0JiU181Tm9vV0dUM1c1NWVMUHNCdlZFVmRSZXpmRFp3TnBQUVJXYnFYV1VlNVBIZXU0TzY4bE5BNTd4NGpIT21aYlZHMy1qSW1HWDFH?oc=5","date":"2026-04-06","type":"pipeline","source":"BioSpace","summary":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees - BioSpace","headline":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAJBVV95cUxPdVluTC16UjhUVG5IcU9tX0EwOGtTS0p3cUR0c05jTDMyU2J3SEVxbFpBTjFCLVctTUxOZlVCcHEtcHFva3doXzdVR3IxOVFEQjVvMlI3cW1kOGVQaEk1a0RzWEEtc0J4YnhjaVNKcHBUeE8xZmNhc19DbFR2UUE3RTE4dnJMY3p5WlAyak9XSWFhYXJ0ZGdHY0MtSm03bldkZVRhVmZ4SE9tLUpxaW0xbDlicTVkeHM3T1lFU29DNUhyXzBkeTRQc2lYenV4aEgyTHBPeVJyVGw4Y2FHMUVwUmE1NFpKR0FFRDZfWEhnU3l0UmlCYWd5MEZZWkZYUVl4Zl9SYnNyOUFwUGN2?oc=5","date":"2026-03-23","type":"deal","source":"Business Wire","summary":"Biocytogen Announces Strategic Collaboration with Moonlight Bio to Advance Cell Therapies Using Library of Antibody Binders - Business Wire","headline":"Biocytogen Announces Strategic Collaboration with Moonlight Bio to Advance Cell Therapies Using Library of Antibody Bind","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwJBVV95cUxNQWYwbGQtWnN1TmNuZDYxN0lySS1NSGFzU2pPT3VlangtdnloUnhrUDZsRk5ZSGFNVnhmdm01bmhUMDJCTkpkZXUwNmkxQWREWUk0TFowOWpjQmRXd0R1ajYzX1MzOU5ZUmdHbmdjSU9KVlNpNjdBUDFKbWtvODNPN3JRZXoxUllRN0daSWVxVzhWbmpHaUp6bkxRY3MzY2tWSzlFRjd0ZktuU2sxWTk5SkVCZkpSa0ROeGhKSzdNQnZVdzJxMG1sVWs4MVMxVEU3YzZ4c3RpMFFzYkhGTjh5d1VGRXZ1NFVSTjZjcGkxM3JCeEU4SnpuTnlGaWpqNEFtZFVFSkdnalJkTGI0djluU2xFSDNkTDVKUmVkQXpHSmluVXJIeW01YTdZVWtFaVpTRFY4WEVoYUtHRWc?oc=5","date":"2026-02-04","type":"pipeline","source":"PR Newswire","summary":"Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer - PR Newswire","headline":"Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxOWnU3YnJCYzNuV0Y1RUFWQXpUYlFDTXhGa1hlMnhGRjAyRy01WXNJc05KSmd3RUVKZmV0aUxXWjVPbkV2dkhwb0s1NFdOWTRKSUVvYW8zdFNGSGJQSG5NMzFVQnB3WC12dS1ZQ3VPQnJ0a3pkVzdfTUlaMmV1bEp4VVJ1YS1QTmRBYlpJOGNYQ0c0M3VFcmZyeVhLTnJQcENYcmdkTHNWSmZiam45YlBwRVI0eHhJNkJPX0ZjdE1mZ2hOX0c5dVRNeUZtOU1LUzNpQjJhZ2NwNmpTQlBoSlh0VmpxbDBaWkZQX05YVmlvMFRzZXc2bnBRd2RrS3hNZFphTVhkT2hCc3BMUlliNHd3bXl3ZnJXa3M5NEFqR1ZNdHlERG_SAaMCQVVfeXFMTlp1N2JyQmMzbldGNUVBVkF6VGJRQ014RmtYZTJ4RkYwMkctNVlzSXNOSkpnd0VFSmZldGlMV1o1T25FdnZIcG9LNTRXTlk0SklFb2FvM3RTRkhiUEhuTTMxVUJwd1gtdnUtWUN1T0JydGt6ZFc3X01JWjJldWxKeFVSdWEtUE5kQWJaSThjWENHNDN1RXJmcnlYS05yUHBDWHJnZExzVkpmYmpuOWJQcEVSNHh4STZCT19GY3RNZmdoTl9HOXVUTXlGbTlNS1MzaUIyYWdjcDZqU0JQaEpYdFZqcWwwWlpGUF9OWFZpbzBUc2V3Nm5wUXdka0t4TWRaYU1YZE9oQnNwTFJZYjR3d215d2ZyV2tzOTRBakdWTXR5RERv?oc=5","date":"2026-02-04","type":"trial","source":"Bolsamania","summary":"Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Bolsamania","headline":"Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPQ0IyRmpWZzhoSnhlMVFEdVdtRzM2TjRtN0FfSXp5YjBSMHJVcGZwNlJxR09OODhWQWhIM3NRcV9pdEczQUhiaEs1aXpXYVlRWFlWb1k5QVVfd0t5bmQxRmVGblpDZVM4SmRtN2taaExmRU9KN3BmLU95bVRRM1V4aWtYaEZQVGpZNzRsOEVrSTdVc2FiVTFDcDJhb19DczA5M2IzM0FR?oc=5","date":"2025-12-09","type":"pipeline","source":"BioWorld News","summary":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025 - BioWorld News","headline":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE5XajZhRTNPbGxnZXpFWGhUS291OXN0d0JWUFc3Q01PZXF2TDJucFMtd0cySXMxc25ZNE9GNG05UW96cklUTU5zeFdQWTRiYVItdTVaUFE0aks5SEto?oc=5","date":"2025-11-03","type":"pipeline","source":"EurekAlert!","summary":"16th International Congress on Skin Ageing & Challenges 2025: Innovation. Strategies. Translation. - EurekAlert!","headline":"16th International Congress on Skin Ageing & Challenges 2025: Innovation. Strategies. Translation. - EurekAlert!","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwJBVV95cUxQUnR4eWV5U1NYbGNCcFE2ckFpNU1CUkRVanR4ZUtxSTA3Q0ZRdlhWR2lENEhOTWdJTThLVDkzWU5RUkVsOVEzdGhIc3BVMzBYOUlFdi00bi1jaV9KampMakV5cjc5ZWVvZWwycW9kM1A2U21zNmNkYXBxOEZkRUxIR1dmRnhkX1dLTmFTTXlVV3puUjQtWVp4YjdXYVc1Zi0xTDNYODA3WFVzeDhwS3RydGt1cGprN2R4cVNob2FuMmsyazhTMUtuR1BMcGU3bVFlbmNrUFRNZ3Q3RC1mWmY5Y25YNnFIWENyV1dSYXVCODB1dzdNaXlVc1hLcDNUVUpxZGxwTURoV01aUk1PTVNvNXptTQ?oc=5","date":"2025-09-03","type":"pipeline","source":"Business Wire","summary":"Biocytogen Enters into Agreement with Merck, KGaA, Darmstadt, Germany to Advance Antibody-Conjugated Lipid-Based Delivery Solutions - Business Wire","headline":"Biocytogen Enters into Agreement with Merck, KGaA, Darmstadt, Germany to Advance Antibody-Conjugated Lipid-Based Deliver","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNbzktb0ZpdUxHb0NIMGN5SjFBWG4zTjRCNmdqbHh4ZndyMjRfNHR6Yk1HNXpBVF93d1BlbzBNNGJfSXNNbnh4cGlxbFFiRmpwMmV4Vkd3WHJycDhfM1ZEZE1PcGVBb1htTVM0OW56cFBlZmVXV3FnZjdWcWtqZXV6aEY4RTFqODFNbUFfNVlOeW9kUm5BQUVhXzhudktUOWcxdUdWVlZtLVA?oc=5","date":"2025-08-06","type":"pipeline","source":"BioSpace","summary":"Big Pharma Provides Lifeline to Chinese Companies Struggling To Survive - BioSpace","headline":"Big Pharma Provides Lifeline to Chinese Companies Struggling To Survive","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPMlJzdE1mR2hBOUhxMFZ1RUJBcEhCUGZ3Smthd2hkRFZ0cl9UWl95N3RQQXhxemRHYlBGb2RpbHlIWm9PcWFCeGZkaTRIeHA1dlp5V1RrN3U3LUxMek1pYmhMalhuVG5tZUhXdzRXYWJLNktfYVY0UWJUWGRha043MjQxSEtwVVdxMFlzX25qTDJWSHNFeXNKTVZKeWQxZnFoQ0dj?oc=5","date":"2025-07-17","type":"pipeline","source":"BioWorld News","summary":"34 mainland China biotechs file for Hong Kong IPO in H1 2025 - BioWorld News","headline":"34 mainland China biotechs file for Hong Kong IPO in H1 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQWDlHaEVLaGZST3BHZU9CQjdnSVc1SjdaR1NsdGtldFZ2R3hFTVNBdHJVZzBuRzZ5ZzhHQk9HcXk3WjcyNVBRd3Znczc1TWNmQnNiUHdSRk5TQktaZ1h4TkdyQjZPcl9ueXZUWFZERHdzdUI2MkVnX1NLNmFkU19zMmtJMHJYUnRwNGdjNlRzZHk4eXp6eDVnQjZWcV9oRFE3a0ZhZjN2OFhLV2dUXzhwZ0hB?oc=5","date":"2024-12-02","type":"pipeline","source":"Bloomberg.com","summary":"Big Pharma’s Bet on China Biotech Is a Rare Trade Bright Spot - Bloomberg.com","headline":"Big Pharma’s Bet on China Biotech Is a Rare Trade Bright Spot","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxQYXlpWWtJNGNLZHJEeWRMRnR6R0E2SVY5eElibzV2ZDlyaGZ0cDNLd3Z4V2hIVWpoZlA1LUw5SEd6SHRHbWNva1VQcUExU1FQN1lWV3pBN2M4aUktay16cGpCc2pPc2xsOWlwUzBvMXFGbmduaG5OdE1mZEM5aEdlN3BsNU1LNER4eWtScEpHb1hKUllUWm1OSndEM3MySmF6d3VPY0Q5ZVFjclBWUG5TMGNpODhhYWdiUlFQbV94T0g1T3RyZ2FnOWlhS0Z1c0xpNnExUGJBMTJfSGNGR01paGlveU5mazNqMV9JM1FIX1FlSzUwSjJ4VEtBWjVtWTVfTmpteW9n?oc=5","date":"2024-11-19","type":"regulatory","source":"PR Newswire","summary":"Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum as 120+ Key Companies at the Forefront | DelveInsight - PR Newswire","headline":"Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum as 120+ Key Companies at the Forefront | DelveInsigh","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5SM1dTRGVRbi1aY3ItMlVmMnJhOWU2RmdVbWZ5ZlhLanYxNERlT3lad21uMHVZek5mZmpmRVBjMHI1OWE1MG40VThkYWQ4LTdTUjlB?oc=5","date":"2024-10-20","type":"pipeline","source":"36 Kr","summary":"让一部分人先看到未来 - 36 Kr","headline":"让一部分人先看到未来 - 36 Kr","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_3":4},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}